ARTICLES BY THIS AUTHOR
- 2/20/2025
Apollo, Sycamore, Brigade reportedly vying for Family Dollar
Apollo Global Management, Sycamore Partners and Brigade Capital Management are reportedly interested in acquiring Family Dollar. - 2/19/2025
Axsome, Teva settle litigation over Auvelity
Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted, or on or after Sept. 30, 2038, if no pediatric exclusivity is granted. - 2/19/2025
Amazon to halt support for Chime, shuts down Inspire
Chime allows Amazon's employees to meet, chat and place business calls inside and outside the organization, as a preferred service for video calls. - 2/19/2025
Walgreens adds on-demand delivery from Grubhub to services
Through Grubhub, Walgreens and Duane Reade customers have access to 15,000 items for on-demand delivery. - 2/19/2025
Walmart reports Q4, full year results
Walmart's fourth quarter revenue was $180.6 billion, up 4.1%, while full year revenue was $681 billion, up 5.1%. - 2/18/2025
Alembic releases generic Dilacor
Diltiazem HcL ER capsules are indicated for the treatment of hypertension. - 2/18/2025
CRN welcomes new member companies
These organizations represent a broad spectrum of expertise, spanning ingredient innovation, dosing technology, regulatory compliance, consumer health solutions and more. - 2/18/2025
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi said the closing is expected to take place in Q2 2025 at the earliest. - 2/17/2025
Sycamore Partners' deal with Walgreens reportedly still possible
CNBC reported that private equity firm Sycamore Partners' deal with WBA is still possible. - 2/17/2025
FDA gives GSK OK for Penmenvy meningococcal vaccination
The vaccine combines the antigenic components of GSK’s two meningococcal vaccines, Bexsero and Menveo.